Related Experiment Video
Updated: Jun 23, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Pre-eclampsia in the second pregnancy: does previous outcome matter?
Sohinee Bhattacharya1, Doris M Campbell, Norman C Smith
1Dugald Baird Centre for Research on Women's Health, Aberdeen Maternity Hospital, Cornhill Road, Aberdeen, Scotland AB25 2ZL, UK. sohinee.bhattacharya@abdn.ac.uk
Summary
Previous pregnancy outcomes significantly impact pre-eclampsia risk in subsequent pregnancies. Deliveries after 37 weeks, regardless of outcome, offer protection against developing pre-eclampsia.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
- Perinatal Epidemiology
Background:
- Pre-eclampsia is a serious pregnancy complication with multifactorial etiology.
- Understanding risk factors for recurrent pre-eclampsia is crucial for maternal health.
- Previous pregnancy history is known to influence future pregnancy outcomes.
Purpose of the Study:
- To investigate the association between initial pregnancy characteristics and the risk of developing pre-eclampsia in a second pregnancy.
- To identify specific pregnancy outcomes and gestational ages that modify pre-eclampsia risk.
Main Methods:
- An observational study utilized data from the Aberdeen Maternity and Neonatal Databank (1986-2006).
- Women who developed pre-eclampsia in their second pregnancy were cases; normotensive women were controls.
- Logistic regression analysis was employed to calculate crude and adjusted odds ratios for various risk factors.
Main Results:
- A history of pre-eclampsia in the first pregnancy increased the risk by over 5 times (aOR 5.12).
- Previous second-trimester pregnancy loss (aOR 4.22), very preterm (aOR 2.32), and preterm births (aOR 1.62) significantly elevated pre-eclampsia risk.
- Longer inter-pregnancy intervals (≥6 years) and increased BMI were associated with higher risk, while a change of partner showed a protective effect.
Conclusions:
- Only initial deliveries at or beyond 37 weeks of gestation, irrespective of the pregnancy outcome, demonstrated a protective effect against pre-eclampsia in the second pregnancy.
- Specific adverse outcomes in the first pregnancy are strong predictors of pre-eclampsia in subsequent pregnancies.
Related Concept Videos
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...